In some patients, a positive glycaemic response (rise in the plasma glucose concentration of >1.5 mmol/L from baseline) following an intramuscular/intravenous injection of glucagon at the time of hypoglycaemia provides supportive evidence (39). The gene discussed is GCG; the disease is Hypoglycemia.